Clinical Trial Update: A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon® [Phase 4]

View source ↗

Summary

A multicenter, randomized, double-blind non-inferiority Phase 4 trial evaluating Entelon for diabetic retinopathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Entelon

Snippet

Sponsor: Hanyang University | Conditions: Diabetic Retinopathy | Phase 4 | Status: COMPLETED